Treatment of the scorpion envenoming syndrome: 12-years experience with serotherapy.
The pathophysiology of the scorpion envenoming syndrome is described with emphasis on the body systems commonly affected. Concepts of the mechanisms underlying venom action, as can be explained by the recently discovered effects on ionic channels, are discussed. A protocol for the treatment of scorpion stings based mainly on antivenom therapy was applied nationwide in Saudi Arabia. A list of drugs with alternatives was specified to be used in adjunctive therapy, when required. Analysis of the outcome from 1,033 cases at Al-Baha region, 791 cases at Al-Qassim region and more than 2,000 cases from 12 central and specialist hospitals in the Central Province, Saudi Arabia gave impressive results. The incidence of severe venom toxicity following antivenom administration was almost negligible. The period of stay in the hospital was reduced. The early reaction to antivenom administration was lower than expected the severity of the reaction consisting mainly of skin rashes, urticaria, wheezing and bronchial hypersensitivity, but no anaphylaxis. About 13.8% of the victims had been previously treated with antivenom but only 1.7% of the patients showed positive skin tests. This might be due to the low protein content of the antivenom and the action of the venom in releasing massive amounts of catecholamines.
Ismail
M
M
Graduate Studies and Research, October 6 University, 6th of October City, Main Center 111, Egypt. ajmadmi@gega.net
D018712:Analgesics, Non-Narcotic / Q000627:therapeutic use; D000818:Animals; D000927:Anticonvulsants / Q000627:therapeutic use; D000932:Antiemetics / Q000627:therapeutic use; D000997:Antivenins / Q000627:therapeutic use; D006801:Humans; D007116:Immunization, Passive; D010276:Parasympatholytics / Q000627:therapeutic use; D012529:Saudi Arabia; D065008:Scorpion Stings / Q000188:drug therapy / Q000503:physiopathology / Q000517:prevention & control / Q000628:therapy*; D012604:Scorpion Venoms / Q000506:poisoning*; D012605:Scorpions; D013577:Syndrome; D014665:Vasodilator Agents / Q000627:therapeutic use
D018712:Analgesics, Non-Narcotic; D000927:Anticonvulsants; D000932:Antiemetics; D000997:Antivenins; D010276:Parasympatholytics; D012604:Scorpion Venoms; D014665:Vasodilator Agents